Cellectis S.A.
CMVLF
$4.50
-$0.54-10.71%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.35M | -59.00M | -60.53M | -36.76M | -84.48M |
| Total Depreciation and Amortization | 20.03M | 19.74M | 19.45M | 19.09M | 19.13M |
| Total Amortization of Deferred Charges | 758.00K | 758.00K | 758.00K | 758.00K | 69.00K |
| Total Other Non-Cash Items | 20.44M | 27.09M | 18.13M | -13.76M | 20.59M |
| Change in Net Operating Assets | -34.96M | -21.94M | 51.34M | 53.67M | 107.44M |
| Cash from Operations | -29.09M | -33.35M | 29.14M | 22.99M | 62.75M |
| Capital Expenditure | -2.43M | -2.03M | -2.76M | -2.58M | -2.31M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.17M | -40.80M | -93.77M | -100.23M | -97.49M |
| Cash from Investing | -68.60M | -42.82M | -96.53M | -102.81M | -99.80M |
| Total Debt Issued | 6.88M | 6.99M | 6.95M | 23.20M | 17.71M |
| Total Debt Repaid | -15.86M | -15.84M | -15.87M | -16.06M | -16.35M |
| Issuance of Common Stock | 206.00K | 206.00K | 83.03M | 83.03M | 129.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -925.00K | -1.01M | -979.00K | -1.05M | -2.78M |
| Cash from Financing | -9.70M | -9.65M | 73.13M | 89.11M | 127.77M |
| Foreign Exchange rate Adjustments | 533.00K | -3.41M | -1.07M | -2.75M | 1.01M |
| Miscellaneous Cash Flow Adjustments | 2.00K | -1.00K | 0.00 | 0.00 | -2.00K |
| Net Change in Cash | -106.85M | -89.23M | 4.66M | 6.54M | 91.73M |